Are there any side effects of BPC 157?

BPC 157 has potential side effects, primarily related to its role in angiogenesis and possible tumor growth. Here are the key points discussed by Andrew Huberman:

1. Angiogenesis: BPC 157 promotes the formation of new blood vessels (angiogenesis) through the upregulation of vascular endothelial growth factor (VEGF). This mechanism is similar to certain cancer treatments that inhibit VEGF to reduce tumor growth. Therefore, there's a concern that stimulating angiogenesis could potentially encourage tumor growth in individuals predisposed to cancer 1.

2. Lack of Human Data: Despite animal studies demonstrating promising results in tissue repair, the lack of extensive human data highlights the need for caution. The long-term effects and true safety profile in humans remain unclear 1.

3. Monitoring Health Metrics: Users should take the minimal effective dose (300-500 micrograms) and avoid continuous use. It’s essential to monitor health metrics for signs that could indicate tumor development or other adverse outcomes 1.

4. General Precautions: While many users report benefits, such as enhanced recovery from injuries, the potential risks associated with BPC 157 necessitate careful consideration and medical oversight, especially for those with a history of cancer 1.

In summary, while BPC 157 may offer benefits for recovery, users should be aware of its risks, particularly concerning tumor growth, and should consult healthcare professionals for guidance.